Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
AC
Acurx Pharmaceuticals, Inc. Common Stock
ACXP
Mkt Cap
$4.7M
Volume
163.96K
Next Earnings
November 11th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
AC
ACXP
AC
Acurx Pharmaceuticals, Inc. Common Stock
ACXP
News
·
Biodefense Market to Attain USD 32.87 Billion by 2034, Driven by Biotech Advancements and Government Funding
Mkt Cap
$5.0M
Volume
163.96K
Next Earnings
November 11th
Chart
Financials
Earnings
News
About
Insider
Filings
Biodefense Market to Attain USD 32.87 Billion by 2034, Driven by Biotech Advancements and Government Funding
The global biodefense market is projected to grow from USD 16.81 billion in 2024 to USD 32.87 billion by 2034, driven by advancements in biotechnology, increased government funding, and growing awareness of biological threats.
GlobeNewswire Inc. · Oct 31, 2025
Why Alcoa Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Shares of Alcoa Corporation (NYSE: AA) rose sharply in today’s pre-market trading after the company reported better-than-expected sales for its first quarter. The company reported quarterly losses of 81 cents per share, according to data from Benzinga Pro. Alcoa still sees full-year alumina production of between 9.8 million and 10 million metric tons and full-year alumina shipments between 12.7 million and 12.9 million metric tons. Alcoa shares jumped 3% to $36.60 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers Tian Ruixiang Holdings Ltd (NASDAQ: TIRX) shares gained 155.6% to $1.24 in pre-market trading after gaining around 8% on Wednesday. MicroCloud Hologram Inc. (NASDAQ: HOLO) gained 51.8% to $3.40 in pre-market trading after falling around 5% on Wednesday. Smart for Life, Inc. (NASDAQ: SMFL) shares gained 28.4% to $0.6035 in pre-market trading after gaining over 21% on Wednesday. Tantech Holdings ...
Benzinga · Apr 18, 2024
Why Airspan Networks Shares Are Trading Higher By Over 380%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Airspan Networks Holdings Inc. (NASDAQ: MIMO) shares rose sharply during Wednesday’s session after the company announced a partnership with GCT Semiconductor to develop an RF module. Airspan Networks Holdings shares surged 381% to $0.3699 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers Treasure Global Inc. (NASDAQ: TGL) gained 31% to $0.1144. LQR House Inc. (NASDAQ: LQR) gained 30.4% to $2.6344 after dipping 45% on Tuesday. LQR House announced an increase of its share buyback program to $5 million. ProQR Therapeutics N.V. (NASDAQ: PRQR) rose 29% to $3.2123. Safety Shot, Inc. (NASDAQ: SHOT) climbed 26.7% to $2.2692. Safety Shot responded to FSD Pharma's unauthorized tagging of its stock and making false claims in an effort to harm the company and its shareholders. Bullfrog AI Holdings, Inc. (NASDAQ: BFRG) gained 27% to $3.3626 after the company reported early results from its collaboration with Lieber Institute for Brain Development (LIBD). Fitell Corporation (NASDAQ: FTEL) rose 25.7% to $1.2451. Kintara Therapeutics, Inc. (NASDAQ: KTRA) shares climbed 25.6% to $0.1594 after falling more than 9% on Tuesday. Cognition Therapeutics, Inc. (NASDAQ: CGTX) gained 22.4% to $2.5339. Rail Vision Ltd. (NASDAQ: RVSN) rose 22% to $2.0510 as the company said that a leading US-based rail and leasing services company signed a supply contract with Rail Vision valued at up to $5,000,000 for the purchase of Rail Vision’s AI-based Switch Yard Systems. Digital World Acquisition Corp. (NASDAQ: DWAC) jumped 17.5% to $26.25 after Donald Trump recently won the Iowa GOP caucus. Digital World Acquisition Corp is the business combination partner of Trump Media & Technology Group. American Coastal Insurance Corporation ...
Benzinga · Jan 17, 2024
Why Bluegreen Vacations Shares Are Trading Higher By Around 105%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Carbon Revolution Public Limited (NASDAQ: CREV) shares jumped 396.2% to $145.49 after gaining 100% on Friday. The company’s stock began trading on Friday following merger with Twin Ridge Capital Acquisition Corp. Bluegreen Vacations Holding Corporation (NYSE: BVH) gained 105.8% to $73.11 after the company announced it would be acquired by Hilton Grand Vacations at $75 per share. Verb Technology Company, Inc. (NASDAQ: VERB) shares climbed 59.5% to $0.4086 amid the company announcing new technology integrations for its MARKET.live platform. MSP Recovery, Inc. (NASDAQ: LIFW) jumped 34.7% to $3.69. Digital Brands Group, Inc. (NASDAQ: DBGI) shares gained 34.3% to $5.87 after the company announced review of strategic alternatives. Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) jumped 32.7% to $0.4971. Organigram Holdings Inc. (NASDAQ: OGI) gained 28.8% to $1.48 after the company announced a C$124.6 million investment from BAT and the creation of "Jupiter" strategic investment pool. Cheetah Net Supply Chain Service Inc. (NASDAQ: CTNT) rose 26% to $1.45. Celldex Therapeutics, Inc. (NASDAQ: CLDX) gained 23.5% to $32.09 after the company announced data from its phase 2 trial treating urticaria refractory. RiskOn International, Inc. (NASDAQ: ROI) climbed 23.2% to $0.8499. Napco Security Technologies, Inc. (NASDAQ: NSSC) surged 20.8% to $22.72 following strong quarterly sales. Freshpet, Inc. (NASDAQ: FRPT) gained 20.2% to $69.99. Freshpet reported third-quarter FY23 sales growth of 32.6% year-on-year to $200.60 million, beating the analyst consensus estimate of $194.11 million. reAlpha Tech Corp. (NASDAQ: AIRE) gained 20% to $10.79. PainReform Ltd. (NASDAQ: PRFX) climbed 18.7% to $2.79 Indaptus Therapeutics, Inc. (NASDAQ:
Benzinga · Nov 6, 2023
Why BEST Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Gainers Carbon Revolution Public Limited (NASDAQ: CREV) shares surged 358% to $134.37 in pre-market trading after gaining 100% on Friday. The company’s stock began trading on Friday following merger with Twin Ridge Capital Acquisition Corp. Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) shares rose 25.8% to $0.8686 in pre-market trading. Sensei Biotherapeutics reported clinical data for SNS-101 at 2023 SITC Annual Meeting. Digital Brands Group, Inc. (NASDAQ: DBGI) shares gained 21.7% to $5.28 in pre-market trading after falling around 4% on Friday. Warrantee Inc. (NASDAQ: WRNT) rose 21.4% to $0.45 in pre-market trading after gaining 11% on Friday. RiceBran Technologies (NASDAQ: RIBT) shares climbed 21% to $0.4744 in pre-market trading after gaining 7% on Friday. POSCO Holdings Inc. (NYSE: PKX) shares jumped 18.1% to $98.51 in pre-market trading. Shares of South Korea ...
Benzinga · Nov 6, 2023
Top 3 Health Care Stocks That May Implode This Quarter
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is ...
Benzinga · Oct 16, 2023
Why InMode Shares Are Trading Lower By 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers OpGen, Inc. (NASDAQ: OPGN) jumped 593% to $2.33 following two SEC filings from the precision medicine company. The company has received an advanced payment of €750,000 related to the sale of certain Unyvero A50 systems by Curetis to a strategic partner. OpGen also announced a Preferred Stock Purchase Agreement. It signed an agreement with a certain investor to acquire 1,000 shares priced at $1,000 each, with gross proceeds of $1 million. Secoo Holding Limited (NASDAQ: SECO) shares climbed 577.7% to $2.17 after gaining around 12% on Wednesday. Versus Systems Inc. (NASDAQ: VS) shares jumped 305% to $0.8728 after gaining around 7% on Wednesday. Jaguar Health, Inc. (NASDAQ: JAGX) shares climbed 90.1% to $0.4601, after gaining over 3% on Wednesday. Atreca, Inc. (NASDAQ: BCEL) gained 87% to $0.4424. ReShape Lifesciences Inc. (NASDAQ: RSLS) shares gained 56.8% to $0.4235. ReShape Lifesciences was granted U.S. patent #11779482 for "Intragrastric Device for Treating Obesity." BSQUARE Corporation (NASDAQ: BSQR) rose 48.4% to $1.84. Kontron America agreed to acquire BSQUARE for $1.90 per share in an all-cash transaction, representing an implied equity value of $38 million. Edesa Biotech, Inc. (NASDAQ: EDSA) gained 37% to $3.70. Edesa Biotech recently announced a one-for-seven reverse share split. LL Flooring Holdings, Inc. (NYSE: LL) jumped 35% to $3.9800. Live Ventures submitted a proposal to acquire LL Flooring for $5.85 per share in cash. Scholar Rock Holding Corporation (NASDAQ: SRRK) gained 28.8% to $8.82. Scholar Rock priced upsized $85 million public offering of 12,408,760 common shares at $6.85 per share. LogicMark, Inc. (NASDAQ: LGMK) jumped 27% to $1.9824. Genetron Holdings Limited (NASDAQ: GTH) gained 26% to $1.1994. Genetron Health entered into definitive merger agreement for going private transaction. Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) jumped 24% to $4.65. The company recently announced the successful completion and early discontinuation of the Ibezapolstat Phase 2b trial for the treatment of C. difficile infection. Blue Star Foods Corp. (NASDAQ: BSFC) gained 23% ...
Benzinga · Oct 12, 2023
Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022
Upgrades For NRG Energy Inc (NYSE:NRG), B of A Securities upgraded the previous rating of Underperform to Neutral. For the third quarter, NRG Energy had an EPS of $0.29, compared to year-ago quarter EPS of $6.60. At the moment, the stock has a 52-week-high of $47.82 and a 52-week-low of $30.64. NRG Energy closed at $31.05 at the end of the last trading period. According to Northland Capital Markets, the prior rating for Enphase Energy Inc (NASDAQ:ENPH) was changed from Market Perform to Outperform. In the third quarter, Enphase Energy showed an EPS of $1.25, compared to $0.60 from the year-ago quarter. At the moment, the stock has a 52-week-high of $339.92 and a 52-week-low of $113.40. Enphase Energy closed at $303.39 at the end of the last trading period. According to Raymond James, the prior rating for American Equity Investment Life Holding Co (NYSE:AEL) was changed from Outperform to Strong Buy. For the third quarter, American Equity Inv had an EPS of $1.29, compared to year-ago quarter EPS of $0.85. At the moment, the stock has a 52-week-high of $44.49 and a 52-week-low of $28.05. American Equity Inv closed at $39.13 at the end of the last trading period. Stifel upgraded the previous rating for Pentair PLC (NYSE:PNR) from Hold to Buy. For the third quarter, Pentair had an EPS of $0.99, compared to year-ago quarter EPS of $0.89. The current stock performance of Pentair shows a 52-week-high of $74.76 and a 52-week-low of $38.55. Moreover, at the end of the last trading period, the closing price was at $43.44. Atlantic Equities upgraded the previous rating for Warner Music Group Corp (NASDAQ:WMG) from Neutral to Overweight. Warner Music Gr earned $0.32 in the fourth quarter, compared to $0.12 in the year-ago quarter. The stock has a 52-week-high of $44.64 and a 52-week-low of $21.57. At the end of the last trading period, Warner Music Gr closed at $33.64. According to Jefferies, the prior rating for Moderna Inc (NASDAQ:MRNA) was changed from Hold to Buy. Moderna earned $2.53 in the third quarter, compared to $7.70 in the year-ago quarter. At the moment, the stock has a 52-week-high of $321.31 and a 52-week-low of $115.03. Moderna closed at $193.29 at the end of the last trading period. JP Morgan upgraded the previous rating for Glaukos Corp (NYSE:GKOS) from Underweight to Neutral. In the third quarter, Glaukos showed an EPS of $0.45, compared to $0.21 from the year-ago quarter. The stock has a 52-week-high of $64.49 and a 52-week-low of $33.33. At the end of the last trading period, Glaukos closed at $42.48. Keybanc upgraded the previous rating for PerkinElmer Inc (NYSE:PKI) from Sector Weight to Overweight. PerkinElmer earned $1.51 in the third quarter, compared to $2.31 in the year-ago quarter. At the moment, the stock has a 52-week-high of $203.16 and a 52-week-low of $113.46. PerkinElmer closed at $137.66 at the end of the last trading period. See all analyst ratings upgrades. Downgrades According to TD Securities, the prior rating for Maxar Technologies Inc (NYSE:MAXR) was changed from Buy to Tender. For the third quarter, Maxar Technologies had an EPS of $0.05, compared to year-ago quarter EPS of $0.19. The stock has a 52-week-high of $51.93 and a 52-week-low of $17.51. At the end of the last trading period, Maxar Technologies closed at $51.93. According to B of A Securities, the prior rating for American Electric Power Co Inc (NASDAQ:AEP) was changed from Buy to Neutral. For the third quarter, American Electric Power had an EPS of $1.62, compared to year-ago quarter EPS of $1.43. At the moment, the stock has a 52-week-high of $105.60 and a 52-week-low of $80.30. American Electric Power closed at $94.57 at the end of the last trading period. For Raymond James Financial Inc (NYSE:RJF), Keefe, Bruyette & Woods downgraded the previous rating of Outperform to Market Perform. In the fourth quarter, Raymond James Finl showed an EPS of $2.08, compared to $2.06 from the year-ago quarter. At the moment, the stock has a 52-week-high of $126.00 and a 52-week-low of $84.86. Raymond James Finl closed at $106.75 at the end of the last trading period. For Synaptogenix Inc (NASDAQ:SNPX), Maxim Group downgraded the previous rating of Buy to Hold. Synaptogenix earned $0.43 in the third quarter, compared to $0.47 in the year-ago quarter. The stock has a 52-week-high of $10.65 and a 52-week-low of $1.08. At the end of the last trading period, Synaptogenix closed at $1.20. According to TD Securities, the prior rating for Louisiana-Pacific Corp (NYSE:LPX) was changed from Buy to Hold. In the third quarter, Louisiana-Pacific showed an EPS of $1.72, compared to $3.87 from the year-ago quarter. The current stock performance of Louisiana-Pacific shows a 52-week-high of $79.77 and a 52-week-low of $48.20. Moreover, at the end of the last trading period, the closing price was at $61.85. According to RBC Capital, the prior rating for Maxar Technologies Inc (NYSE:MAXR) was changed from Outperform to Sector Perform. Maxar Technologies earned $0.05 in the third quarter, compared to $0.19 in the year-ago quarter. At the moment, the stock has a 52-week-high of $51.93 and a 52-week-low of $17.51. Maxar Technologies closed at $51.93 at the end of the last trading period. For AT&T Inc (NYSE:T), MoffettNathanson downgraded the previous rating of Market Perform to Underperform. For the third quarter, AT&T had an EPS of $0.68, compared to year-ago quarter EPS of $0.87. The stock has a ...Full story available on Benzinga.com
Benzinga · Dec 19, 2022
The Daily Biotech Pulse: NRx's Zyesami Face Regulatory Rejection, Puma Slumps On Q3 Miss, Pfizer Has Good Tidings On Oral Antiviral COVID-19 Pill
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus NRx's COVID-19 Drug Fails to Get Authorization From FDA Due To Insufficient Data NRx Pharmaceuticals (NASDAQ: NRXP) announced that the U.S. Food and Drug Administration has declined to issue an emergency use authorization for Zyesami. The FDA stated it was unable to issue the EUA at this time due to insufficient data regarding the known and potential benefits of the medicine and the known and potential risks of it in patients suffering from critical COVID-19 with respiratory failure. The stock was slumping 25.90% to $6.61 in premarket trading. Novavax Files With The WHO For Authorization Of COVID Vaccine Candidate Novavax, Inc. (NASDAQ: NVAX) announced the completion of its rolling submission to the World Health Organization for emergency use listing of NVX-CoV2373, its COVID-19 vaccine candidate. Separately, the company reported third-quarter results that trailed expectations. The stock was adding 5.35% to $189 in after-hours trading. Click here to access Benzinga's FDA Calendar Opiant's Opioid Overdose Drug Gets FDA's Fast Track Designation Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) said the FDA has granted fast track designation for OPNT003, nasal nalmefene, its investigational treatment for opioid overdose. The stock was moving up 2.18% to $23 in premarket trading. Calithera Pulls The Plug On Mid-Stage Lung Cancer Study Due to Lack of Clinical Benefit (NASDAQ: CALA) announced the decision to terminate its phase 2 KEAPSAKE clinical trial based on a lack of clinical benefit observed in patients treated with telaglenastat in an interim analysis. The investigational asset is being evaluated with chemotherapy in first-line KEAP1/NRF2-mutated, non-squamous non-small cell lung cancer. The stock was down 29.47% to $1.34 in premarket trading. Pfizer Reports Positive Phase 2/3 Data For Oral Antiviral COVID Pill Pfizer, Inc. (NYSE: PFE) anounced its investigational novel COVID-19 oral antiviral candidate, Paxlovid significantly reduced hospitalization and death, based on an interim analysis of the Phase 2/3 EPIC-HR study of non-hospitalized adult patients with COVID-19, who are at high risk of progressing ...
Benzinga · Nov 5, 2021
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV) Alkermes plc (NASDAQ: ALKS) Century Therapeutics Inc (NASDAQ: IPSC) Gilead Sciences, Inc. (NASDAQ: GILD) GlaxoSmithKline plc (NYSE: GSK) Edward Lifesciences Corp (NYSE: EW) Eli Lilly and Company (NYSE: LLY) (announced reorganization of business units) Innoviva Inc (NASDAQ: INVA) Intuitive Surgical, Inc. (NASDAQ: ISRG) Johnson & Johnson (NYSE: JNJ) Maravai Lifesciences Holdings Inc (NASDAQ: MRVI) NanoVibronix, Inc. (NASDAQ: NAOV) Novo Nordisk A/S (NYSE: NVO) Nuvalent Inc (NASDAQ: NUVL) Omega Therapeutics Inc (NASDAQ: OMGA) Pfizer, Inc. (NYSE: PFE) Regeneron Pharmaceuticals Inc (NASDAQ: REGN) (moved on news COVID-19-affected Texas Governor Greg Abbott is being treated with the company's antibody treatment) Quest Diagnostics Incorporated (NYSE: DGX) ResMed Inc. (NYSE: RMD) Virpax Pharmaceuticals Inc (NASDAQ: VRPX) (moved on announcement regarding FDA response for pursuing MMS019 as a prophylactic treatment against SARS and influenza viruses for daily use as an OTC product) West Pharmaceutical Services, Inc. (NYSE: WST) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Aug. 17) 4D pharma plc (NASDAQ: LBPS) Absci Corporation (NASDAQ: ABSI) ABVC BioPharma, Inc. (NASDAQ: ABVC) ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) (reacted to its second-quarter results) Achieve Life Sciences, Inc. (NASDAQ: ACHV) Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (announced its second-quarter results) Adaptive Biotechnologies Corporation (NASDAQ: ADPT) Adicet Bio Inc (NASDAQ: ACET) Adverum Biotechnologies, Inc. (NASDAQ: ADVM) ADMA Biologics Inc (NASDAQ: ADMA) Agile Therapeutics, Inc. (NASDAQ: AGRX) Akouos Inc (NASDAQ: AKUS) Akoya Biosciences, Inc. (NASDAQ: AKYA) Alzamend Neuro Inc (NASDAQ: ALZN) Angion Biomedica Corp. (NASDAQ: ANGN) Applied Genetic Technologies Corporation (NASDAQ: AGTC) Aptinyx Inc. (NASDAQ: APTX) Aptose Biosciences Inc. (NASDAQ: APTO) Aravive, Inc. (NASDAQ: ARAV) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) Assertio Holdings, Inc. (NASDAQ: ASRT) Athenex, Inc. (NASDAQ: ATNX) Athira Pharma, Inc. (NASDAQ: ATHA) (announced its second-quarter results) Avenue Therapeutics, Inc. (NASDAQ: ATXI) AVITA Medical, Inc. (NASDAQ: RCEL) Axsome Therapeutics, Inc. (NASDAQ: AXSM) Aytu Biopharma, Inc. (NASDAQ: AYTU) AzurRx BioPharma Inc (NASDAQ: AZRX) Biocept Inc (NASDAQ: BIOC) (reacted to its quarterly results) Biodesix, Inc. (NASDAQ: BDSX) Biomea Fusion, Inc. (NASDAQ: BMEA) BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) BioXcel Therapeutics Inc. (NASDAQ: BTAI) Caladrius Biosciences, Inc. (NASDAQ: CLBS) Candel Therapeutics Inc (NASDAQ: CADL) (IPOed July 30) Catalyst Biosciences Inc (NASDAQ: CBIO) Cellectis S.A. (NASDAQ: CLLS) Chemomab Therapeutics Ltd. (NASDAQ: CMMB) CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Concert Pharmaceuticals Inc (NASDAQ: CNCE) ContraFect Corporation (NASDAQ: CFRX) Cue Biopharma Inc (NASDAQ: CUE) CymaBay Therapeutics Inc (NASDAQ: CBAY) CytomX Therapeutics Inc (NASDAQ: CTMX) Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) DURECT Corporation (NASDAQ: DRRX) Edgewise Therapeutics, Inc. (NASDAQ: EWTX) Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) Ensysce Biosciences, Inc. (NASDAQ: ENSC) (announced its second-quarter results) Enveric Biosciences, Inc. (NASDAQ: ENVB) Epizyme, ...
Benzinga · Aug 18, 2021
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
AC
ACXP
Acurx Pharmaceuticals, Inc. Common Stock
Buy
Sell
Market
Limit
Soon
ACXP
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any ACXP yet.
Related Tickers
Earnings